ResourcesEvaluating Pharmaceutical Policy Options Resources / healnetwork1 NBER Working Paper No. 32606
ResourcesThe Relationship Between Biopharma R&D Investment and Expected Returns: Improving Evidence to Inform Policy Resources / healnetwork1
ResourcesNot Again: Why the United States Can’t Afford to Lose Its Biopharma Industry Resources / healnetwork1
ResourcesWhat Universities Are Saying About the Biden Administration’s Draft Framework for March-In Rights Resources / healnetwork1
